Skip to main content
. Author manuscript; available in PMC: 2024 Jul 25.
Published in final edited form as: Am J Geriatr Psychiatry. 2023 Sep 3;32(1):98–113. doi: 10.1016/j.jagp.2023.08.017

FIGURE 2.

FIGURE 2.

Clinical trials for FTD-GRN and FTD)/ALS-C9orf72. The table lists the drug, target disease, mechanism of action, status, and registration number. The Venn diagram at the bottom provides a visual representation of the drug distributions based on target disease and mutation. AAV, adeno-associated virus; ALS, amyotrophic lateral sclerosis; FTD, frontotemporal dementia; mAb, monoclonal antibody.